GlySure (United Kingdom) a clinical-stage medical device company focused on a intravascular, optical fluorescence-based sensor for continuous blood glucose monitoring systems, closed a $10.9M Series C financing. Participants include Morningside Venture, Amadeus Capital Partners, Chester Investments and Delta Partners.